DOI:
10.1055/s-00035148
Schlaf
LinksClose Window
References
Salardini E, Zeinoddini A, Kohi A, Mohammadi M, Mohammadinejad P, Khiabany M. et al.
Agomelatine as a Treatment for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Double-Blind, Randomized Clinical Trial.
J Child Adolesc Psychopharmacol 2016;
26 (06) 513-9.
We do not assume any responsibility for the contents of the web pages of other providers.